Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2019		Dec. 31, 2018
Current Assets
Cash and cash equivalents (variable interest entity restricted - 2019: $57; 2018: $24)	$ 463		$ 439
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2019: $9; 2018: $10; variable interest entity restricted - 2019: $6; 2018: $6)	850		1,017
Non-trade receivables, net	331		301
Inventories	1,038		1,046
Marketable securities	40		31
Other assets	43		40
Total current assets	2,765		2,874
Investments in affiliates	975		979
Property, plant and equipment (net of accumulated depreciation - 2019: $2,957; 2018: $2,803; variable interest entity restricted - 2019: $622; 2018: $659)	3,713		3,719
Operating lease right-of-use assets	203		0
Deferred income taxes	96		84
Other assets (variable interest entity restricted - 2019: $9; 2018: $5)	338		290
Goodwill	1,074	[1]	1,057
Intangible assets, net (variable interest entity restricted - 2019: $22; 2018: $23)	312		310
Total assets	9,476		9,313
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	496		561
Trade payables - third party and affiliates	780		819
Other liabilities	461		343
Income taxes payable	17		56
Total current liabilities	1,754		1,779
Long-term debt, net of unamortized deferred financing costs	3,409		2,970
Deferred income taxes	257		255
Uncertain tax positions	165		158
Operating Lease, Liability, Noncurrent	181		0
Benefit obligations	589		564
Other liabilities	223		208
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2019 and 2018: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2019: 168,973,172 issued and 119,555,207 outstanding; 2018: 168,418,954 issued and 128,095,849 outstanding)	0		0
Treasury stock, at cost (2019: 49,417,965 shares; 2018: 40,323,105 shares)	(3,846)		(2,849)
Additional paid-in capital	254		233
Retained earnings	6,399		5,847
Accumulated other comprehensive income (loss), net	(300)		(247)
Total Celanese Corporation stockholders' equity	2,507		2,984
Noncontrolling interests	391		395
Total equity	2,898		3,379
Total liabilities and equity	$ 9,476		$ 9,313

[1] There were $0 million of accumulated impairment losses as of December 31, 2019.